Cargando…

GDF-11 as a Potential Cardiac Pro-Angiogenic Factor

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Kato, Tomohiro, Lee, Richard T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322875/ https://www.ncbi.nlm.nih.gov/pubmed/37426538 http://dx.doi.org/10.1016/j.jacbts.2023.04.003

Ejemplares similares

GDF11/Myostatin and aging
por: Patel, Vishal K., et al.
Publicado: (2014)

Neuroprotective Potential of GDF11: Myth or Reality?
por: Rochette, Luc, et al.
Publicado: (2019)

Structural basis for potency differences between GDF8 and GDF11
por: Walker, Ryan G., et al.
Publicado: (2017)

Cardiac Myosin Protein C: New Roles, New Questions, Potential Opportunities
por: Blanton, Robert M., et al.
Publicado: (2017)

Pro-malignant properties of STAT3 during chronic inflammation
por: Demaria, Marco, et al.
Publicado: (2012)

The emerging translational potential of GDF11 in chronic wound healing
por: Li, Yuan, et al.
Publicado: (2022)

Platelet-Derived Growth Factors: A New Therapeutic Opportunity for Treating Cardiac Fibrosis?
por: Mouton, Alan J.
Publicado: (2023)

Exogenous GDF11, but not GDF8, reduces body weight and improves glucose homeostasis in mice
por: Walker, Ryan G., et al.
Publicado: (2020)

Factor Xa Inhibition, A New Strategy for Prevention of Adverse Cardiac Remodeling in Early Stages?
por: Bozkurt, Biykem
Publicado: (2020)

Growth differentiation factor 11 (GDF11) has pronounced effects on skin biology
por: Idkowiak-Baldys, Jolanta, et al.
Publicado: (2019)

GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone
por: Suh, Joonho, et al.
Publicado: (2020)

Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism
por: van der Wall, E. E., et al.
Publicado: (2010)

Aging, Aortic Stenosis, and Transthyretin Cardiac Amyloidosis: A Perfect Cardiac Storm?
por: Bokhari, Sabahat, et al.
Publicado: (2021)

Connecting the Dots for Connective Tissue Growth Factor Roles in Cardiac Wound Healing After Myocardial Infarction
por: Hale, Taben M., et al.
Publicado: (2019)

Functional replacement of myostatin with GDF-11 in the germline of mice
por: Lee, Se-Jin, et al.
Publicado: (2022)

Ankylosing Spondylitis and Cardiac Abnormalities
por: Yang, Dong Heon
Publicado: (2012)

Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors
por: Marek-Trzonkowska, Natalia, et al.
Publicado: (2015)

Deficiency of GDF-11 Accelerates TAC-Induced Heart Failure by Impairing Cardiac Angiogenesis
por: Zhu, Jinyun, et al.
Publicado: (2023)

Anti-Aging Effects of GDF11 on Skin
por: Rochette, Luc, et al.
Publicado: (2020)

Control of the Immune Response by Pro-Angiogenic Factors
por: Voron, Thibault, et al.
Publicado: (2014)

Functional substitutions of amino acids that differ between GDF11 and GDF8 impact skeletal development and skeletal muscle
por: Lian, John, et al.
Publicado: (2023)

September 11, 01
por: Petsko, Gregory A
Publicado: (2001)

Vitamin C for Cardiac Surgery Patients: Several Errors in a Published Meta-Analysis. Comment on “Effects of Vitamin C on Organ Function in Cardiac Surgery Patients: A Systematic Review and Meta-Analysis. Nutrients 2019, 11, 2103”
por: Hemilä, Harri, et al.
Publicado: (2020)

Drugging the Hippo (Pathway): A Strategy to Stimulate Cardiac Regeneration?
por: Mani, Kartik, et al.
Publicado: (2018)

The history of the cardiac emergency room, and the patient’s history
por: Peters, R. J. G.
Publicado: (2014)

Optimisation of cardiac resynchronisation therapy during exercise
por: Ghani, A., et al.
Publicado: (2013)

TGF-β Inhibitor CILP as a Novel Biomarker for Cardiac Fibrosis
por: Groß, Sonja, et al.
Publicado: (2020)

Similar sequences but dissimilar biological functions of GDF11 and myostatin
por: Suh, Joonho, et al.
Publicado: (2020)

Cardiac resynchronization therapy; evaluation by advanced imaging techniques
por: van der Wall, E. E., et al.
Publicado: (2009)

Cardiac magnetic resonance imaging; gatekeeper in suspected CAD?
por: van der Wall, E. E., et al.
Publicado: (2010)

Red blood transfusion in patients undergoing cardiac surgery
por: Noyez, L.
Publicado: (2014)

Applying Modern Transcriptomics to Interrogate the Human Cardiac Fibroblast
por: Kanisicak, Onur, et al.
Publicado: (2016)

ECMO in children post cardiac surgery-opportunity for redress
por: Alwi, Mazeni
Publicado: (2017)

Fragmented QRS frequency in patients with cardiac syndrome X
por: Bacharova, Ljuba
Publicado: (2016)

EDITORIAL COMMENT: LACK OF EVIDENCE OF HPV ETIOLOGY OF PROSTATE CANCER FOLLOWING RADICAL SURGERY AND HIGHER FREQUENCY OF THE ARG/PRO GENOTYPE IN TURKISH MEN WITH PROSTATE CANCER
por: Pontes, Jose
Publicado: (2017)

Editorial Comment to Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinoma
por: Uehara, Sho
Publicado: (2020)

Cardiac magnetic resonance imaging in primary PCI: additional value?
por: van der Wall, E. E., et al.
Publicado: (2009)

Evidence of scar tissue: contra-indication to cardiac resynchronization therapy?
por: van der Wall, E. E., et al.
Publicado: (2010)

The reduction of post-cardiac surgery infections by statins: solid evidence?
por: Bekkers, S. C. A. M.
Publicado: (2014)

Cardiac Sympathetic-Parasympathetic Interaction: The Endless Story of Yin and Yang
por: Dusi, Veronica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r0jinpnt6soeup3aeld3gqkh7m